According to Mereo BioPharma Group's latest financial reports the company's current revenue (TTM) is S$11.72 M. In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of S$64.27 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.